アフターアワーズ： 39.17

Rhythm Pharmaceuticals Inc. (RYTM)

Rhythm Pharmaceuticals Inc. (RYTM) 最新ニュース

Rhythm Pharmaceuticals Inc. (RYTM)

Rhythm Pharmaceuticals Inc. (RYTM) 最新ニュース

Victory Capital Management Inc. Has $8.38 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Joseph Shulman Sells 3984 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - Defense World

Rhythm Pharmaceuticals CTO sells shares worth over $150,000 By Investing.com - Investing.com

Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 3,984 Shares of Stock - MarketBeat

Bank of America Downgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to Neutral - Defense World

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $54.33 - Defense World

Investors in Rhythm Pharmaceuticals (NASDAQ:RYTM) have unfortunately lost 65% over the last year - Yahoo Canada Shine On

New York State Common Retirement Fund Grows Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewswire

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Acquired by National Bank of Canada FI - MarketBeat

December 2025 Options Now Available For Rhythm Pharmaceuticals (RYTM) - Nasdaq

RYTM Shares Experience Decline in Value – Knox Daily - Knox Daily

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $46.00 Price Target at Needham & Company LLC - Defense World

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $79.00 by Analysts at Canaccord Genuity Group - MarketBeat

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Rhythm Pharmaceuticals stock downgraded by BofA on sales outlook - Investing.com South Africa

Bank of America Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) to Neutral - MarketBeat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat

Rhythm Pharmaceuticals stock downgraded by BofA on sales outlook - Investing.com Canada

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript - Insider Monkey

Rhythm Pharmaceuticals stock downgraded by BofA on sales outlook - Investing.com UK

Rhythm Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Earnings call: Rhythm Pharmaceuticals sees steady IMCIVREE growth - Investing.com Canada

Rhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of Financial and ... - GuruFocus.com

Bank of America Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) to Neutral - MarketBeat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $46.00 - MarketBeat

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates

Rhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challenges - GuruFocus.com

Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update - Yahoo Finance

Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting - Yahoo Finance

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo New Zealand News

Rhythm Pharmaceuticals, Inc.'s (NASDAQ:RYTM) Shares May Have Run Too Fast Too Soon - Simply Wall St

(RYTM) Investment Analysis and Advice - Stock Traders Daily

A stock that deserves closer examination: Rhythm Pharmaceuticals Inc. (RYTM) – US Post News - US Post News

First Week of June 21st Options Trading For Rhythm Pharmaceuticals (RYTM) - Nasdaq

Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline - Yahoo Finance

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of ... - Yahoo Finance

Analyst Expectations For Rhythm Pharmaceuticals's Future

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Commit To Purchase Rhythm Pharmaceuticals At $25, Earn 8.6% Annualized Using Options - Nasdaq

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know

Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?

Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst - Seeking Alpha

Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing

Rhythm Pharmaceuticals secures $150 million in funding By Investing.com - Investing.com

RYTMに似た銘柄